I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Cheryl Scott Biography and Net Worth

Director of Evolent Health

Cheryl Scott is currently the Main Principal at the McClintock Scott Group. Until she retired in July 2016, she was the Senior Advisor at the Bill & Melinda Gates Foundation, providing strategy counsel and support. She joined the Foundation in 2006 as Chief Operating Officer, overseeing all major operational functions. Scott was previously president and CEO of the Seattle-based Group Health Cooperative. Her eight-year tenure as CEO capped a distinguished 25-year career with Group Health, which also included roles as the organization’s Executive Vice President and Chief Operating Officer. Scott received her bachelor’s degree in communications and master’s degree in health management from the University of Washington. She currently serves on a variety of private and not-for-profit boards. In 2005, the University of Washington and Group Health created the Cheryl M. Scott/Group Health Cooperative Professorship in Health Care Leadership in the School of Public Health. Scott is a frequent speaker at health policy forums and is also a clinical professor in the University of Washington Department of Health Services.

What is Cheryl Scott's net worth?: The estimated net worth of Cheryl Scott is at least $115,218.18 as of June 28th, 2024. Ms. Scott owns 10,098 shares of Evolent Health stock worth more than $115,218 as of December 21st. This net worth estimate does not reflect any other investments that Ms. Scott may own. Learn More about Cheryl Scott's net worth.
How do I contact Cheryl Scott?: The corporate mailing address for Ms. Scott and other Evolent Health executives is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. Evolent Health can also be reached via phone at (571) 389-6000 and via email at [email protected]. Learn More on Cheryl Scott's contact information.
Has Cheryl Scott been buying or selling shares of Evolent Health?: Cheryl Scott has not been actively trading shares of Evolent Health over the course of the past ninety days. Most recently, Cheryl Scott sold 2,365 shares of the business's stock in a transaction on Wednesday, June 14th. The shares were sold at an average price of $30.01, for a transaction totalling $70,973.65. Following the completion of the sale, the director now directly owns 53,788 shares of the company's stock, valued at $1,614,177.88. Learn More on Cheryl Scott's trading history.
Who are Evolent Health's active insiders?: Evolent Health's insider roster includes Seth Blackley (Co-Founder, CEO & Director), Mary Duffy (Director), Diane Holder (Director), John Johnson (CFO), Daniel Mccarthy (President), Emily Rafferty (COO), Cheryl Scott (Director), Steve Tutewohl (COO), Jonathan Weinberg (General Counsel), and Frank Williams (Chairman). Learn More on Evolent Health's active insiders.
Are insiders buying or selling shares of Evolent Health?: In the last year, insiders at the technology company sold shares 5 times. They sold a total of 307,291 shares worth more than $9,290,384.77. The most recent insider tranaction occured on August, 22nd when President Daniel Joseph Mccarthy sold 23,693 shares worth more than $731,876.77. Insiders at Evolent Health own 1.6% of the company. Learn More about insider trades at Evolent Health.
Information on this page was last updated on 8/22/2024.

Cheryl Scott Insider Trading History at Evolent Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/14/2023	Sell	2,365	$30.01	$70,973.65	53,788
6/11/2021	Sell	6,405	$19.39	$124,192.95
6/11/2018	Sell	1,600	$22.63	$36,208.00
5/19/2017	Sell	5,477	$23.51	$128,764.27

Cheryl Scott Buying and Selling Activity at Evolent Health

Evolent Health Company Overview

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Today's Range

Now: $11.41

$10.96

$11.52

50 Day Range

MA: $16.65

$10.71

$27.14

2 Week Range

Now: $11.41

$10.53

$35.00

Volume

3,134,905 shs

Average Volume

1,868,250 shs

Market Capitalization

$1.33 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.45

I was wrong. Dead wrong.

From Porter & Company | Ad